Yusuf Hamied Department of Chemistry, University of Cambridge, CB2 1EW Cambridge, U.K.
J Am Chem Soc. 2024 Jul 31;146(30):20709-20719. doi: 10.1021/jacs.4c03721. Epub 2024 Jul 16.
Chemical post-translational protein-protein conjugation is an important technique with growing applications in biotechnology and pharmaceutical research. Maleimides represent one of the most widely employed bioconjugation reagents. However, challenges associated with the instability of first- and second-generation maleimide technologies are yet to be fully addressed. We report the development of a novel class of maleimide reagents that can undergo on-demand ring-opening hydrolysis of the resulting thio-succinimide. This strategy enables rapid post-translational assembly of protein-protein conjugates. Thio-succinimide hydrolysis, triggered upon application of chemical, photochemical, or enzymatic stimuli, allowed homobifunctional bis-maleimide reagents to be applied in the production of stable protein-protein conjugates, with complete temporal control. Bivalent and bispecific protein-protein dimers constructed from small binders targeting antigens of oncological importance, PD-L1 and HER2, were generated with high purity, stability, and improved functionality compared to monomeric building blocks. The modularity of the approach was demonstrated through elaboration of the linker moiety through a bioorthogonal propargyl handle to produce protein-protein-fluorophore conjugates. Furthermore, extending the functionality of the homobifunctional reagents by temporarily masking reactive thiols included in the linker allowed the assembly of higher order trimeric and tetrameric single-domain antibody conjugates. The potential for the approach to be extended to proteins of greater biochemical complexity was demonstrated in the production of immunoglobulin single-domain antibody conjugates. On-demand control of thio-succinimide hydrolysis combined with the facile assembly of chemically defined homo- and heterodimers constitutes an important expansion of the chemical methods available for generating stable protein-protein conjugates.
化学翻译后蛋白质-蛋白质偶联是一种重要的技术,在生物技术和药物研究中有广泛的应用。马来酰亚胺代表了最广泛使用的生物偶联试剂之一。然而,第一代和第二代马来酰亚胺技术的不稳定性相关挑战尚未得到充分解决。我们报告了一类新型马来酰亚胺试剂的开发,这些试剂可以按需开环水解生成的硫代琥珀酰亚胺。这种策略能够快速进行蛋白质-蛋白质偶联物的翻译后组装。硫代琥珀酰亚胺水解,在应用化学、光化学或酶刺激时触发,允许同双功能双马来酰亚胺试剂应用于稳定的蛋白质-蛋白质偶联物的生产,具有完全的时间控制。由针对肿瘤相关抗原 PD-L1 和 HER2 的小结合物靶向的二价和双特异性蛋白质-蛋白质二聚体构建,与单体构建块相比,具有更高的纯度、稳定性和改进的功能。该方法的模块化通过通过生物正交炔丙基手柄修饰连接子部分来证明,以产生蛋白质-蛋白质-荧光团缀合物。此外,通过暂时掩蔽连接子中包含的反应性硫醇来扩展同双功能试剂的功能,允许组装更高阶的三聚体和四聚体单域抗体缀合物。该方法扩展到具有更高生化复杂性的蛋白质的潜力在免疫球蛋白单域抗体缀合物的生产中得到了证明。硫代琥珀酰亚胺水解的按需控制与化学定义的同型和异型二聚体的易于组装相结合,构成了用于生成稳定蛋白质-蛋白质缀合物的化学方法的重要扩展。